Adel Rafeh El Boueiz, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pulmonary Disease, Chronic Obstructive | 18 | 2022 | 3033 | 2.170 |
Why?
|
Pulmonary Emphysema | 5 | 2022 | 683 | 1.270 |
Why?
|
Disease Progression | 13 | 2022 | 13302 | 0.780 |
Why?
|
Bronchitis, Chronic | 2 | 2021 | 66 | 0.770 |
Why?
|
Spirometry | 5 | 2021 | 867 | 0.600 |
Why?
|
Forced Expiratory Volume | 6 | 2021 | 1725 | 0.580 |
Why?
|
Bronchodilator Agents | 2 | 2019 | 510 | 0.510 |
Why?
|
Vital Capacity | 3 | 2021 | 912 | 0.470 |
Why?
|
Smoking | 6 | 2021 | 8932 | 0.450 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 3 | 2010 | 739 | 0.430 |
Why?
|
alpha 1-Antitrypsin | 1 | 2022 | 179 | 0.410 |
Why?
|
Polyadenylation | 1 | 2021 | 113 | 0.410 |
Why?
|
Bronchitis | 1 | 2021 | 209 | 0.390 |
Why?
|
Emphysema | 1 | 2022 | 220 | 0.390 |
Why?
|
Heterozygote | 3 | 2022 | 2791 | 0.360 |
Why?
|
Xanthine Dehydrogenase | 2 | 2008 | 21 | 0.350 |
Why?
|
Activin Receptors, Type I | 1 | 2019 | 145 | 0.350 |
Why?
|
Professional Practice | 1 | 2010 | 331 | 0.340 |
Why?
|
Genetic Variation | 4 | 2021 | 6658 | 0.330 |
Why?
|
Muscular Atrophy | 1 | 2021 | 353 | 0.320 |
Why?
|
Capillary Permeability | 4 | 2009 | 856 | 0.320 |
Why?
|
Diagnostic Self Evaluation | 1 | 2019 | 229 | 0.310 |
Why?
|
Respiratory Function Tests | 5 | 2022 | 1671 | 0.310 |
Why?
|
Lung | 6 | 2020 | 9765 | 0.300 |
Why?
|
Hospitalists | 1 | 2010 | 296 | 0.300 |
Why?
|
Proton Pump Inhibitors | 1 | 2010 | 478 | 0.290 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2021 | 842 | 0.280 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2019 | 653 | 0.270 |
Why?
|
Genetic Predisposition to Disease | 5 | 2022 | 17395 | 0.260 |
Why?
|
Adrenergic beta-Agonists | 1 | 2016 | 358 | 0.260 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2021 | 1479 | 0.260 |
Why?
|
Asthma | 5 | 2021 | 5909 | 0.240 |
Why?
|
Phenotype | 6 | 2022 | 16371 | 0.240 |
Why?
|
Physician's Role | 1 | 2010 | 978 | 0.240 |
Why?
|
Eosinophils | 1 | 2018 | 934 | 0.240 |
Why?
|
Vascular Diseases | 1 | 2021 | 1155 | 0.230 |
Why?
|
Pulmonary Artery | 1 | 2021 | 1901 | 0.230 |
Why?
|
Genome, Human | 2 | 2021 | 4471 | 0.230 |
Why?
|
Genome | 1 | 2020 | 1750 | 0.220 |
Why?
|
Vitamin D Deficiency | 1 | 2020 | 1367 | 0.190 |
Why?
|
Scleroderma, Systemic | 2 | 2010 | 302 | 0.190 |
Why?
|
Population Surveillance | 1 | 2021 | 2631 | 0.190 |
Why?
|
Academic Medical Centers | 1 | 2010 | 2787 | 0.190 |
Why?
|
Severity of Illness Index | 7 | 2022 | 16011 | 0.190 |
Why?
|
Respiratory Insufficiency | 1 | 2017 | 1133 | 0.190 |
Why?
|
Aged | 21 | 2022 | 162674 | 0.190 |
Why?
|
Middle Aged | 25 | 2022 | 214871 | 0.190 |
Why?
|
Tomography, X-Ray Computed | 7 | 2022 | 20398 | 0.180 |
Why?
|
Lung Diseases | 3 | 2008 | 1897 | 0.180 |
Why?
|
Herpes Genitalis | 1 | 2010 | 133 | 0.180 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2021 | 317 | 0.180 |
Why?
|
Reactive Nitrogen Species | 1 | 2008 | 34 | 0.180 |
Why?
|
MAP Kinase Kinase 2 | 1 | 2009 | 108 | 0.180 |
Why?
|
Stress, Mechanical | 3 | 2010 | 1705 | 0.180 |
Why?
|
Genotype | 2 | 2022 | 12921 | 0.170 |
Why?
|
Genome-Wide Association Study | 5 | 2020 | 11907 | 0.170 |
Why?
|
Pleura | 1 | 2009 | 231 | 0.170 |
Why?
|
Toxocara canis | 1 | 2007 | 1 | 0.160 |
Why?
|
Molecular Epidemiology | 1 | 2019 | 484 | 0.160 |
Why?
|
Toxocariasis | 1 | 2007 | 11 | 0.160 |
Why?
|
Respiratory Mucosa | 1 | 2021 | 462 | 0.160 |
Why?
|
Models, Theoretical | 1 | 2020 | 3563 | 0.160 |
Why?
|
Hyperuricemia | 1 | 2010 | 214 | 0.160 |
Why?
|
Chondrosarcoma | 1 | 2009 | 295 | 0.160 |
Why?
|
Herpes Simplex | 1 | 2010 | 470 | 0.150 |
Why?
|
Bronchi | 1 | 2021 | 847 | 0.150 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2010 | 720 | 0.150 |
Why?
|
Protein Isoforms | 2 | 2021 | 1709 | 0.150 |
Why?
|
Apolipoprotein E4 | 1 | 2010 | 616 | 0.150 |
Why?
|
Models, Statistical | 1 | 2021 | 5028 | 0.150 |
Why?
|
Adrenal Cortex Hormones | 1 | 2016 | 1847 | 0.150 |
Why?
|
Male | 27 | 2022 | 351081 | 0.150 |
Why?
|
Respiration, Artificial | 3 | 2009 | 2452 | 0.140 |
Why?
|
Female | 25 | 2022 | 377334 | 0.140 |
Why?
|
Pulmonary Alveoli | 1 | 2008 | 730 | 0.140 |
Why?
|
Herpesvirus 1, Human | 1 | 2010 | 727 | 0.130 |
Why?
|
Longitudinal Studies | 5 | 2022 | 13573 | 0.130 |
Why?
|
Lung Injury | 1 | 2009 | 402 | 0.130 |
Why?
|
Heat-Shock Proteins | 1 | 2009 | 890 | 0.130 |
Why?
|
Humans | 36 | 2022 | 715124 | 0.130 |
Why?
|
Antioxidants | 1 | 2012 | 1689 | 0.130 |
Why?
|
Quality of Life | 2 | 2021 | 11691 | 0.120 |
Why?
|
Risk Assessment | 2 | 2022 | 23511 | 0.110 |
Why?
|
Prospective Studies | 6 | 2022 | 51181 | 0.110 |
Why?
|
Vitamin D | 2 | 2020 | 3163 | 0.110 |
Why?
|
Actins | 1 | 2009 | 2187 | 0.100 |
Why?
|
Aortic Diseases | 1 | 2007 | 723 | 0.100 |
Why?
|
Reactive Oxygen Species | 1 | 2008 | 2148 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2010 | 2592 | 0.100 |
Why?
|
Lung Volume Measurements | 1 | 2021 | 361 | 0.100 |
Why?
|
Aged, 80 and over | 8 | 2022 | 58505 | 0.100 |
Why?
|
Adiposity | 1 | 2010 | 1743 | 0.100 |
Why?
|
Cluster Analysis | 2 | 2022 | 2746 | 0.100 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2010 | 2960 | 0.090 |
Why?
|
Sex Characteristics | 1 | 2010 | 2536 | 0.090 |
Why?
|
3' Untranslated Regions | 1 | 2021 | 523 | 0.090 |
Why?
|
Extravascular Lung Water | 1 | 2009 | 20 | 0.090 |
Why?
|
Drug Utilization Review | 1 | 2010 | 258 | 0.090 |
Why?
|
Mucus | 1 | 2021 | 315 | 0.090 |
Why?
|
Tomography | 1 | 2021 | 360 | 0.090 |
Why?
|
Skin Diseases | 1 | 2008 | 1090 | 0.090 |
Why?
|
Cohort Studies | 5 | 2021 | 39804 | 0.090 |
Why?
|
Cardiomyopathies | 1 | 2010 | 1829 | 0.090 |
Why?
|
Protein C | 1 | 2009 | 152 | 0.090 |
Why?
|
Linear Models | 2 | 2020 | 5980 | 0.090 |
Why?
|
Quantitative Trait Loci | 2 | 2021 | 1979 | 0.080 |
Why?
|
Molecular Sequence Annotation | 1 | 2020 | 547 | 0.080 |
Why?
|
Jurkat Cells | 1 | 2019 | 797 | 0.080 |
Why?
|
Dementia | 1 | 2010 | 2254 | 0.080 |
Why?
|
Survival Analysis | 2 | 2022 | 10531 | 0.080 |
Why?
|
Risk Factors | 6 | 2022 | 70704 | 0.070 |
Why?
|
Insulin Resistance | 1 | 2010 | 3890 | 0.070 |
Why?
|
Logistic Models | 3 | 2019 | 13594 | 0.070 |
Why?
|
Neoplasm Proteins | 1 | 2009 | 3777 | 0.070 |
Why?
|
Cognition Disorders | 1 | 2010 | 3987 | 0.070 |
Why?
|
Multivariate Analysis | 2 | 2020 | 12477 | 0.070 |
Why?
|
Exons | 1 | 2021 | 2476 | 0.070 |
Why?
|
Acute Lung Injury | 1 | 2009 | 381 | 0.070 |
Why?
|
Kidney Failure, Chronic | 1 | 2008 | 2567 | 0.070 |
Why?
|
Genetic Markers | 1 | 2022 | 2690 | 0.070 |
Why?
|
Genomics | 1 | 2021 | 5333 | 0.070 |
Why?
|
Predictive Value of Tests | 2 | 2022 | 15258 | 0.070 |
Why?
|
Multifactorial Inheritance | 1 | 2022 | 1148 | 0.060 |
Why?
|
Adult | 10 | 2022 | 212129 | 0.060 |
Why?
|
Genetics, Population | 1 | 2020 | 990 | 0.060 |
Why?
|
Leukocyte Count | 1 | 2018 | 1677 | 0.060 |
Why?
|
ROC Curve | 1 | 2021 | 3526 | 0.060 |
Why?
|
Thrombosis | 1 | 2007 | 2852 | 0.060 |
Why?
|
Administration, Inhalation | 1 | 2016 | 1104 | 0.060 |
Why?
|
Depression | 1 | 2012 | 7256 | 0.060 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2021 | 15584 | 0.060 |
Why?
|
Prognosis | 3 | 2021 | 29168 | 0.060 |
Why?
|
United States | 6 | 2021 | 67665 | 0.060 |
Why?
|
Comorbidity | 2 | 2017 | 10423 | 0.050 |
Why?
|
Pedigree | 1 | 2020 | 4722 | 0.050 |
Why?
|
Apoptosis | 1 | 2008 | 10112 | 0.050 |
Why?
|
Follow-Up Studies | 3 | 2018 | 39285 | 0.050 |
Why?
|
Poisson Distribution | 1 | 2012 | 515 | 0.050 |
Why?
|
Obesity | 2 | 2021 | 12192 | 0.050 |
Why?
|
Analysis of Variance | 2 | 2010 | 6531 | 0.050 |
Why?
|
Cytochrome P-450 CYP2D6 | 1 | 2021 | 107 | 0.050 |
Why?
|
Cholesterol, LDL | 1 | 2020 | 2371 | 0.050 |
Why?
|
DNA Mutational Analysis | 1 | 2020 | 4311 | 0.050 |
Why?
|
Glycoproteins | 1 | 2009 | 2313 | 0.050 |
Why?
|
Population Density | 1 | 2021 | 184 | 0.050 |
Why?
|
T-Lymphocyte Subsets | 1 | 2019 | 1909 | 0.050 |
Why?
|
Models, Genetic | 1 | 2020 | 3513 | 0.050 |
Why?
|
INDEL Mutation | 1 | 2021 | 268 | 0.050 |
Why?
|
Gastroesophageal Reflux | 1 | 2016 | 717 | 0.050 |
Why?
|
Proteomics | 1 | 2022 | 3256 | 0.050 |
Why?
|
Likelihood Functions | 1 | 2012 | 986 | 0.050 |
Why?
|
Signal Transduction | 2 | 2010 | 23973 | 0.040 |
Why?
|
Caspase 7 | 1 | 2008 | 53 | 0.040 |
Why?
|
Computational Biology | 1 | 2021 | 3557 | 0.040 |
Why?
|
Odds Ratio | 1 | 2022 | 9968 | 0.040 |
Why?
|
Pleural Effusion, Malignant | 1 | 2009 | 99 | 0.040 |
Why?
|
Carotenoids | 1 | 2012 | 684 | 0.040 |
Why?
|
Quality Control | 1 | 2021 | 869 | 0.040 |
Why?
|
Enzyme Inhibitors | 2 | 2010 | 3933 | 0.040 |
Why?
|
Sample Size | 1 | 2021 | 813 | 0.040 |
Why?
|
Self Report | 1 | 2018 | 3420 | 0.040 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2010 | 1918 | 0.040 |
Why?
|
Young Adult | 4 | 2020 | 56155 | 0.040 |
Why?
|
Phosphorylation | 2 | 2009 | 8738 | 0.040 |
Why?
|
Ventilators, Mechanical | 1 | 2009 | 261 | 0.040 |
Why?
|
Computer Simulation | 1 | 2020 | 6075 | 0.040 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2008 | 436 | 0.040 |
Why?
|
Mutagenesis | 1 | 2021 | 1290 | 0.040 |
Why?
|
Cardiovascular Diseases | 2 | 2021 | 14326 | 0.040 |
Why?
|
Caspase 3 | 1 | 2008 | 801 | 0.040 |
Why?
|
Nutrition Surveys | 1 | 2012 | 1562 | 0.040 |
Why?
|
Cross-Sectional Studies | 2 | 2020 | 23283 | 0.030 |
Why?
|
Drug Therapy, Combination | 1 | 2016 | 6538 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2009 | 12567 | 0.030 |
Why?
|
Demography | 1 | 2010 | 1621 | 0.030 |
Why?
|
Gene Expression Profiling | 1 | 2021 | 9521 | 0.030 |
Why?
|
Risk-Taking | 1 | 2010 | 990 | 0.030 |
Why?
|
Proportional Hazards Models | 1 | 2019 | 12404 | 0.030 |
Why?
|
Molecular Chaperones | 1 | 2009 | 758 | 0.030 |
Why?
|
Absorptiometry, Photon | 1 | 2010 | 1697 | 0.030 |
Why?
|
Haplotypes | 1 | 2021 | 2882 | 0.030 |
Why?
|
Mental Recall | 1 | 2010 | 1204 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2022 | 21790 | 0.030 |
Why?
|
Fibrosis | 1 | 2010 | 1944 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2010 | 15260 | 0.030 |
Why?
|
Mice, Inbred C57BL | 3 | 2010 | 22936 | 0.030 |
Why?
|
Prevalence | 2 | 2010 | 14869 | 0.030 |
Why?
|
Animals | 7 | 2010 | 170726 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 2022 | 12425 | 0.030 |
Why?
|
Gene Frequency | 1 | 2010 | 3713 | 0.030 |
Why?
|
Gene Expression | 2 | 2021 | 8010 | 0.030 |
Why?
|
Cell Line, Tumor | 1 | 2019 | 16943 | 0.030 |
Why?
|
Transcription Factors | 1 | 2022 | 12047 | 0.030 |
Why?
|
Sex Factors | 1 | 2016 | 10651 | 0.030 |
Why?
|
Genetic Association Studies | 1 | 2010 | 2720 | 0.020 |
Why?
|
Child | 2 | 2018 | 74146 | 0.020 |
Why?
|
Leukocytes | 1 | 2008 | 2102 | 0.020 |
Why?
|
Mice | 4 | 2010 | 80995 | 0.020 |
Why?
|
Hypertension, Pulmonary | 1 | 2010 | 1494 | 0.020 |
Why?
|
Health Surveys | 1 | 2010 | 4021 | 0.020 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2010 | 6198 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2010 | 6779 | 0.020 |
Why?
|
Radiography | 1 | 2009 | 6994 | 0.020 |
Why?
|
rho-Associated Kinases | 1 | 2009 | 282 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2008 | 3163 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2010 | 6922 | 0.020 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2009 | 852 | 0.020 |
Why?
|
Pulmonary Edema | 1 | 2009 | 423 | 0.020 |
Why?
|
Pulmonary Circulation | 1 | 2009 | 736 | 0.020 |
Why?
|
Capillaries | 1 | 2009 | 778 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 2009 | 1951 | 0.020 |
Why?
|
Blood Glucose | 1 | 2010 | 6293 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 2019 | 3489 | 0.020 |
Why?
|
Mutation | 1 | 2020 | 29442 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2019 | 62186 | 0.010 |
Why?
|
Diet | 1 | 2010 | 7582 | 0.010 |
Why?
|
Adolescent | 2 | 2010 | 84999 | 0.010 |
Why?
|
Incidence | 1 | 2010 | 20596 | 0.010 |
Why?
|
Models, Biological | 1 | 2008 | 9895 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2019 | 72255 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2009 | 3994 | 0.010 |
Why?
|
Receptors, Cell Surface | 1 | 2009 | 2916 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2008 | 18345 | 0.010 |
Why?
|
Time Factors | 1 | 2008 | 41081 | 0.010 |
Why?
|